Procter & Gamble (NYSE:PG) Issues FY 2026 Earnings Guidance
by Jessica Moore · The Cerbat GemProcter & Gamble (NYSE:PG – Get Free Report) updated its FY 2026 earnings guidance on Friday. The company provided earnings per share guidance of 6.830-7.090 for the period, compared to the consensus earnings per share estimate of 6.950. The company issued revenue guidance of $85.1 billion-$88.5 billion, compared to the consensus revenue estimate of $86.6 billion.
Analyst Upgrades and Downgrades
A number of analysts recently weighed in on the stock. Rothschild & Co Redburn upped their target price on shares of Procter & Gamble from $155.00 to $157.00 and gave the stock a “neutral” rating in a research note on Friday, January 23rd. Jefferies Financial Group lowered their price target on shares of Procter & Gamble from $179.00 to $175.00 and set a “buy” rating for the company in a report on Monday. Wells Fargo & Company dropped their price objective on shares of Procter & Gamble from $177.00 to $158.00 and set an “overweight” rating on the stock in a research report on Wednesday, April 8th. Royal Bank Of Canada reduced their price objective on shares of Procter & Gamble from $172.00 to $167.00 and set an “outperform” rating on the stock in a report on Thursday, April 9th. Finally, Barclays decreased their price objective on shares of Procter & Gamble from $155.00 to $146.00 and set an “equal weight” rating for the company in a research report on Tuesday, April 14th. Twelve equities research analysts have rated the stock with a Buy rating and ten have given a Hold rating to the stock. According to data from MarketBeat, Procter & Gamble has an average rating of “Moderate Buy” and a consensus target price of $162.37.
Check Out Our Latest Report on Procter & Gamble
Procter & Gamble Stock Performance
Shares of PG opened at $145.77 on Friday. The stock has a 50 day moving average price of $150.56 and a 200 day moving average price of $148.72. The company has a quick ratio of 0.51, a current ratio of 0.72 and a debt-to-equity ratio of 0.49. The company has a market capitalization of $338.77 billion, a price-to-earnings ratio of 21.60, a price-to-earnings-growth ratio of 5.50 and a beta of 0.41. Procter & Gamble has a 52-week low of $137.62 and a 52-week high of $170.99.
Procter & Gamble (NYSE:PG – Get Free Report) last announced its quarterly earnings results on Friday, April 24th. The company reported $1.59 EPS for the quarter, beating the consensus estimate of $1.53 by $0.06. The company had revenue of $21.24 billion for the quarter, compared to analyst estimates of $21.52 billion. Procter & Gamble had a net margin of 19.30% and a return on equity of 32.21%. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. Research analysts predict that Procter & Gamble will post 6.96 EPS for the current fiscal year.
Procter & Gamble Increases Dividend
The business also recently announced a quarterly dividend, which will be paid on Friday, May 15th. Investors of record on Friday, April 24th will be given a $1.0885 dividend. This is a positive change from Procter & Gamble’s previous quarterly dividend of $1.06. The ex-dividend date of this dividend is Friday, April 24th. This represents a $4.35 dividend on an annualized basis and a dividend yield of 3.0%. Procter & Gamble’s payout ratio is 62.67%.
Insider Transactions at Procter & Gamble
In related news, CEO Ma. Fatima Francisco sold 5,549 shares of the business’s stock in a transaction on Friday, February 27th. The shares were sold at an average price of $165.29, for a total value of $917,194.21. Following the completion of the sale, the chief executive officer directly owned 1,029 shares of the company’s stock, valued at $170,083.41. The trade was a 84.36% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CEO Gary A. Coombe sold 36,093 shares of the firm’s stock in a transaction dated Thursday, February 12th. The stock was sold at an average price of $162.33, for a total value of $5,858,976.69. Following the transaction, the chief executive officer directly owned 34,994 shares in the company, valued at approximately $5,680,576.02. The trade was a 50.77% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold 252,715 shares of company stock valued at $40,966,904 over the last quarter. 0.20% of the stock is owned by corporate insiders.
Procter & Gamble News Roundup
Here are the key news stories impacting Procter & Gamble this week:
- Positive Sentiment: Q3 EPS topped estimates: P&G reported $1.59 EPS vs. $1.53 consensus and sales grew ~7%, showing resilient pricing/margin execution. Management reiterated its full‑year outlook. CNBC: Procter & Gamble earnings beat estimates as sales grow 7%
- Positive Sentiment: Brand/product momentum: P&G earned top spot in Fortune’s “Most Innovative Companies” for household products and launched new Febreze TRASH, supporting long‑term organic growth and innovation premium. Fortune recognition Febreze TRASH launch
- Neutral Sentiment: Market previews and commentary set modest expectations going into results; macro/consumer‑sentiment data remain the bigger cyclical risk for staples demand. Yahoo: Earnings, consumer sentiment preview
- Neutral Sentiment: Corporate housekeeping: P&G management publicly refuted a mini‑tender offer (minor market noise, not operational). Yahoo: Mini‑tender discussion
- Negative Sentiment: FY‑2026 guidance came in slightly below Street: EPS guided to $6.83–$7.09 (consensus ~6.95) and revenue guidance midpoint a touch under consensus — this cut in expected growth/beat cadence is the primary driver of the selloff. MarketBeat: Q3 results & guidance
- Negative Sentiment: Quarterly revenue missed estimates ($21.23B vs. $21.52B), suggesting volume weakness offset by pricing — an earnings‑quality concern for some investors. CNBC: Revenue miss details
- Negative Sentiment: Analysts trimmed targets/ratings after the print and guidance (Morgan Stanley, BNP Paribas Exane, BofA among firms lowering PTs), increasing near‑term downside risk from multiple sell‑side revisions. MarketScreener: BNP Paribas PT cut MarketScreener: Morgan Stanley PT cut InsiderMonkey: BofA resin‑cost note
Hedge Funds Weigh In On Procter & Gamble
A number of hedge funds have recently modified their holdings of the business. Brighton Jones LLC grew its position in Procter & Gamble by 51.5% during the 4th quarter. Brighton Jones LLC now owns 40,068 shares of the company’s stock worth $6,717,000 after purchasing an additional 13,617 shares during the last quarter. Taylor Financial Group Inc. raised its holdings in shares of Procter & Gamble by 10.6% in the first quarter. Taylor Financial Group Inc. now owns 2,891 shares of the company’s stock valued at $493,000 after buying an additional 277 shares during the last quarter. Sivia Capital Partners LLC raised its holdings in shares of Procter & Gamble by 19.8% in the second quarter. Sivia Capital Partners LLC now owns 6,144 shares of the company’s stock valued at $979,000 after buying an additional 1,016 shares during the last quarter. Auxano Advisors LLC boosted its stake in shares of Procter & Gamble by 10.8% during the second quarter. Auxano Advisors LLC now owns 7,315 shares of the company’s stock worth $1,165,000 after buying an additional 714 shares during the period. Finally, Schnieders Capital Management LLC. grew its holdings in shares of Procter & Gamble by 2.8% during the second quarter. Schnieders Capital Management LLC. now owns 30,182 shares of the company’s stock worth $4,809,000 after buying an additional 809 shares during the last quarter. 65.77% of the stock is currently owned by hedge funds and other institutional investors.
About Procter & Gamble
Procter & Gamble (NYSE: PG) is a multinational consumer goods company headquartered in Cincinnati, Ohio. Founded in 1837 by William Procter and James Gamble, P&G has grown into one of the world’s largest producers of branded consumer packaged goods. The company focuses on developing, manufacturing and marketing a broad portfolio of household and personal care products sold to consumers and retailers worldwide.
P&G’s product offering spans several core business categories, including Beauty, Grooming, Health Care, Fabric & Home Care, and Baby, Feminine & Family Care.